Prognostic Score Including Gene Mutations in Chronic Myelomonocytic LeukemiaRaphaël Itzykson, Éric Solary, François Dreyfus et al.|Journal of Clinical Oncology|2013Cited by 543
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic <i>IDH2</i> MutationsKatharine Yen, Shinsan M. Su, Jeremy Travins et al.|Cancer Discovery|2017Cited by 457
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)Olivier Kosmider, Véronique Gelsi‐Boyer, Meyling Cheok et al.|Blood|2009Cited by 270
Clonal architecture of chronic myelomonocytic leukemiasRaphaël Itzykson, Éric Solary, Olivier Kosmider et al.|Blood|2013Cited by 268
B-cell tumor development in Tet2-deficient miceEnguerran Mouly, Olivier Bernard|Blood Advances|2018Cited by 49